CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 143 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $50,000 | -25.4% | 12,316 | -19.3% | 0.00% | – |
| Q2 2016 | $67,000 | +1.5% | 15,256 | -12.0% | 0.00% | – |
| Q1 2016 | $66,000 | -88.9% | 17,345 | -54.5% | 0.00% | -100.0% |
| Q4 2015 | $597,000 | -36.3% | 38,089 | -57.1% | 0.00% | -55.6% |
| Q3 2015 | $937,000 | +9.8% | 88,848 | +162.6% | 0.01% | +12.5% |
| Q2 2015 | $853,000 | +228.1% | 33,836 | +262.3% | 0.01% | +300.0% |
| Q1 2015 | $260,000 | -16.9% | 9,339 | -45.5% | 0.00% | -33.3% |
| Q4 2014 | $313,000 | – | 17,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,000 | $3,096,000 | 100.00% |
| TSP Capital Management Group, LLC | 698,674 | $1,549,000 | 0.79% |
| Meditor Group Ltd | 6,312,700 | $2,847,000 | 0.61% |
| Telemetry Investments, L.L.C. | 186,200 | $84,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 1,270,500 | $573,000 | 0.03% |
| Benchmark Capital Advisors | 53,400 | $24,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 80,150 | $36,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 80,000 | $36,000 | 0.01% |
| Centiva Capital, LP | 121,720 | $55,000 | 0.01% |
| Overbrook Management Corp | 48,611 | $22,000 | 0.00% |